This is a limited company view. Sign up for a Free Trial to see everything.

CureVac is a biopharmaceutical company specializing in the prophylactic and therapeutic application of messenger RNA.

B2B
Biotechnology
Healthcare
Pharmaceuticals

Overview

Location

Tuebingen

Founded

2000

Employees

157

Stage

Late

Total funding

$451M

Last funding

a year ago

Acquisitions

0

Growth score

212

Mindshare score

34

Scoring

Deals

$29.5M Private Equity

Landeskreditbank Baden-Württemberg

Nov 10, 2016

$225.0M Private Equity

Sep 14, 2015

$52.0M Series E

Bill & Melinda Gates Foundation

Mar 9, 2015

$80.0M Series D

Dievini

Sep 18, 2012

$34.9M Series C

Dievini

May 10, 2010

$22.0M Series B

DH Capital, OH Beteiligungen

Jan 18, 2006

Employee Growth

Use CureVac's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use CureVac's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Manager Business Development
Manager Early Process Development
Manager Project Management and Grants
Director Program Management RNAoptimizer
Director Program Management CMC
Clinical Project Manager
Manager IT Support & Change Management
Senior Procurement Manager
Regulatory Affairs Manager
Manager Intellectual Property
Process Development Manager Analytics
Head of Biomarkers & Immunoanalysis
Quality Manager Change Control
Project Manager
Bioinformatician
Training Manager
Vice President Development - RNArt
Assistentin der Geschäftsleitung
Regulatory Affairs Manager

Similar Companies

Cerulean Pharma

delivering innovation in women's health
Public|52 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes